Streptokinase antibodies are of clinical importance and they can be measured in half an hour by a simple enzyme-linked immunosorbent assay.
作者信息
Brügemann J, van der Meer J, Bom V J, Lie K I
出版信息
Br Heart J. 1994 Aug;72(2):209-10. doi: 10.1136/hrt.72.2.209-a.
Abstract
摘要
相似文献
1
Streptokinase antibodies are of clinical importance and they can be measured in half an hour by a simple enzyme-linked immunosorbent assay.
Br Heart J. 1994 Aug;72(2):209-10. doi: 10.1136/hrt.72.2.209-a.
2
Should streptokinase be readministered? Insights from recent studies of antistreptokinase antibodies.
Med J Aust. 1994 Jul 18;161(2):100-1.
3
Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase.含链激酶溶栓药物的给药前抗体水平及疗效
Br Heart J. 1994 Sep;72(3):222-5. doi: 10.1136/hrt.72.3.222.
4
Comparative study of the reactivity of natural and mutated streptokinase with total antistreptokinase antibodies in human sera.
Blood Coagul Fibrinolysis. 2012 Dec;23(8):734-8. doi: 10.1097/MBC.0b013e328358e87b.
5
Enzyme-linked immunosorbent assay (ELISA) for streptokinase antibodies.链激酶抗体的酶联免疫吸附测定（ELISA）
Diagn Immunol. 1983;1(2):64-7.
6
A mutant streptokinase lacking the C-terminal 42 amino acids is less reactive with preexisting antibodies in patient sera.
Biochem Biophys Res Commun. 1999 Dec 9;266(1):230-6. doi: 10.1006/bbrc.1999.1793.
7
Assay for antibodies to group C and G streptococcal carbohydrate by enzyme-linked immunosorbent assay.采用酶联免疫吸附测定法检测抗C组和G组链球菌碳水化合物抗体。
J Lab Clin Med. 1986 Mar;107(3):204-9.
8
Antistreptokinase antibodies following a dose of streptokinase.
Ann Pharmacother. 1994 Feb;28(2):204-6.
9
Are streptokinase antibodies clinically important?链激酶抗体在临床上重要吗？
Br Heart J. 1994 Mar;71(3):303-4. doi: 10.1136/hrt.71.3.303-a.
10
Streptokinase resistance: when might streptokinase administration be ineffective?链激酶抵抗：何时使用链激酶可能无效？
Br Heart J. 1992 Nov;68(5):449-53. doi: 10.1136/hrt.68.11.449.
本文引用的文献
1
Anti-streptokinase antibodies inhibit fibrinolytic effects of anistreplase in acute myocardial infarction.
Am J Cardiol. 1993 Aug 15;72(5):462-4. doi: 10.1016/0002-9149(93)91143-6.
2
Rapid enzyme immunoassay of anti-streptokinase antibodies in human plasma.
Clin Chim Acta. 1993 Sep 30;218(2):121-9. doi: 10.1016/0009-8981(93)90176-5.
3
Streptokinase neutralisation titres up to 866 days after intravenous streptokinase for acute myocardial infarction.急性心肌梗死静脉注射链激酶后长达866天的链激酶中和效价。
Br Heart J. 1993 Aug;70(2):119-21. doi: 10.1136/hrt.70.2.119.
4
Are streptokinase antibodies clinically important?
Br Heart J. 1993 Aug;70(2):101-2. doi: 10.1136/hrt.70.2.101.
5
Clinical failure of streptokinase due to an unsuspected high titer of antistreptokinase antibody.由于未被怀疑的高滴度抗链激酶抗体导致链激酶临床治疗失败。
J Am Coll Cardiol. 1984 Jul;4(1):183-5. doi: 10.1016/s0735-1097(84)80339-3.
6
Measurement of antistreptokinase antibodies.抗链激酶抗体的检测
J Am Coll Cardiol. 1985 Jun;5(6):1500. doi: 10.1016/s0735-1097(85)80370-3.
7
A systemic non-lytic state and local thrombolytic failure of anistreplase (anisoylated plasminogen streptokinase activator complex, APSAC) in acute myocardial infarction.急性心肌梗死中阿尼普酶（茴香酰化纤溶酶原链激酶激活剂复合物，APSAC）的全身非溶解状态及局部溶栓失败
Br Heart J. 1990 Dec;64(6):355-8. doi: 10.1136/hrt.64.6.355.
Zotero 插件